drugset / Trial / NCT01657292

Oleogel-S10 Versus Standard of Care in Healing of Grade 2a Burn Wounds

NCT01657292

Phase 3 Completed 61 enrolled Birken AG
RandomizedSingle-groupOpen-labelTreatment

Summary

The main goal of this phase III clinical trial is to show safety and efficacy of Oleogel-S10 in the acceleration of wound healing of grade 2a burn wounds.

Timeline

Start
2012-08
Primary completion
2013-07
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject BIRCH TRITERPENES Small molecule Topical

Indications

No indication recorded.